Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study

Yang, Kunyu, Sheng, Yuhan, Huang, Chaolin, Jin, Yang, Xiong, Nian, Jiang, Ke, Lu, Hongda, Liu, Jing +16 more·2020·The Lancet Oncology

Cited by (579)

Items 101–200 of 579

  1. Clinical characteristics, outcomes, and risk factors for mortality in hospitalized patients with COVID-19 and cancer history: a propensity score-matched study
    Majid Sorouri, Amir Kasaeian, Helia Mojtabavi, Amir Reza Radmard, Shadi Kolahdoozan, Amir Anushiravani, Bardia Khosravi, Seyed Mohammad Pourabbas, Masoud Eslahi, Azin Sirusbakht et al. · 2020 · Infectious Agents and Cancer
  2. COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease
    Periklis Katopodis, Rachel Kerslake, Julie Davies, Harpal Singh Randeva, Kamaljit Kaur Chatha, Marcia Hall, Demetrios A. Spandidos, Vladimir Anikin, Andreas Polychronis, Jan Lukas Robertus et al. · 2021 · International Journal of Molecular Medicine
  3. Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors
    Qiuji Wu, Qian Chu, Hongyan Zhang, Bin Yang, Xudong He, Yahua Zhong, Xianglin Yuan, Melvin L.K. Chua, Conghua Xie · 2020 · 癌症:英文版
  4. Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission
    Qiubai Li, Lei Chen, Qin Li, Wenjuan He, Jianming Yu, Li Chen, Yulin Cao, Wenlan Chen, Di Wu, Fang Dong et al. · 2020 · Leukemia
  5. Mortality of COVID-19 in patients with hematological malignancies versus solid tumors: a systematic literature review and meta-analysis
    Nicole J. Hardy, Charan Thej Reddy Vegivinti, Mansi Mehta, Jade Thurnham, Alexander Mebane, John Michael Pederson, Ranita Tarchand, Jeevan Shivakumar, Peace Olaniran, Ritika Gadodia et al. · 2023 · Clinical and Experimental Medicine
  6. Covid‐19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany
    Khalid Shoumariyeh, Francesca Biavasco, Gabriele Ihorst, Siegbert Rieg, Alexandra Nieters, Winfried V. Kern, Cornelius Miething, Justus Duyster, Monika Martha Engelhardt, Hartmut Bertz · 2020 · Cancer Medicine
  7. Rapid Assessment at Hospital Admission of Mortality Risk From COVID-19: The Role of Functional Status
    Olga Laosa, Laura Pedraza, Alejandro Álvarez‐Bustos, José Antonio Carranza Carnicero, Fernando Rodríguez‐Artalejo, Leocadio Rodríguez‐Mañas · 2020 · Journal of the American Medical Directors Association
  8. Impact of the COVID-19 pandemic on the management of chronic noninfectious respiratory diseases
    Angelica I. Tiotiu, Herberto José Chong‐Neto, András Bikov, Krzysztof Kowal, Paschalis Steiropoulos, Marina Labor, Iván Chérrez-Ojeda, Héctor Badellino, Alexander V. Emelyanov, Rocio Garcia et al. · 2021 · Expert Review of Respiratory Medicine
  9. SARS-COV-2 infection and lung tumor microenvironment
    Naila Malkani, Muhammad Usman Rashid · 2021 · Molecular Biology Reports
  10. The Sum of Fears in Cancer Patients Inside the Context of the COVID-19
    Lucas Poitevin Bandinelli, Felipe Rech Ornell, Lisia Von DIEMEN, Félix Henrique Paim Kessler · 2021 · Frontiers in Psychiatry
  11. Indications for and Contraindications of Immune Checkpoint Inhibitors in Cancer Patients with COVID-19 Vaccination
    Bangyu Luo, Jixi Li, Xianhua Hou, Qiao Yang, Yi Zhou, Jun Ye, Xiao‐Cheng Wu, Yimei Feng, Tianyu Hu, Zhi Zhong Xu et al. · 2021 · Future Oncology
  12. Review on the Oncology Practice in the Midst of COVID-19 Crisis: The Challenges and Solutions
    Pedram Fadavi, Mohammad Houshyari, Amir Shahram Yousefi Kashi, Seyed Alireza Mosavi Jarrahi, Farnaz Roshanmehr, Mohammad Ali Broomand, Saleh Sandoughdaran, Farzad Taghizadeh‐Hesary · 2021 · Asian Pacific Journal of Cancer Prevention
  13. Palliative Care for Cancer Patients During the COVID-19 Pandemic, With Special Focus on Lung Cancer
    Janna Josephus Anna Oda Schoenmaekers, Lizza E.L. Hendriks, M.H.J. van den Beuken-van Everdingen · 2020 · Frontiers in Oncology
  14. Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months
    Begoña de las Heras, Kamal S. Saini, Frances M. Boyle, Felipe Ades, Evandro de Azambuja, Ivana Božović‐Spasojević, Marco Romano, Marta Capelán, Rajeev Prasad, Pugazhenthi Pattu et al. · 2020 · Oncology and Therapy
  15. Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)?
    Georgios Chamilos, Michail S. Lionakis, Dimitrios P. Kontoyiannis · 2020 · Clinical Infectious Diseases
  16. Immunological alternation in COVID-19 patients with cancer and its implications on mortality
    Guangyao Cai, Yue Gao, Shaoqing Zeng, Yang Yu, Xingyu Liu, Dan Liu, Ya Wang, Ruidi Yu, Aakash P. Desai, Chunrui Li et al. · 2021 · OncoImmunology
  17. Impact of active cancer on COVID-19 survival: a matched-analysis on 557 consecutive patients at an Academic Hospital in Lombardy, Italy
    Alexia Francesca Bertuzzi, Michele Ciccarelli, Andrea Marrari, Nicolò Gennaro, Andrea Dipasquale, Laura Giordano, Umberto Cariboni, Vittorio Quagliuolo, Marco Alloisio, Armando Santoro · 2021 · British Journal of Cancer
  18. Correlation of SARS‑CoV‑2 to cancer: Carcinogenic or anticancer? (Review)
    Yingshuang Li, Hua-Cheng Ren, Jian-Hua Cao · 2022 · International Journal of Oncology
  19. Low Incidence of SARS-CoV-2 in Patients with Solid Tumours on Active Treatment: An Observational Study at a Tertiary Cancer Centre in Lombardy, Italy
    Alexia Francesca Bertuzzi, Andrea Marrari, Nicolò Gennaro, Umberto Cariboni, Michele Ciccarelli, Laura Giordano, Vittorio Quagliuolo, Armando Santoro · 2020 · Cancers
  20. COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary
    Thomas Round, Veline L’Esperance, Joanne Bayly, Kate E. Brain, Lorraine Dallas, John G. Edwards, Thomas Haswell, Crispin T. Hiley, Natasha Lovell, Julia McAdam et al. · 2021 · British Journal of Cancer
  21. Prevalence and impact of comorbidities on disease prognosis among patients with COVID-19 in Bangladesh: A nationwide study amid the second wave
    Nadim Sharif, Rubayet Rayhan Opu, Shamsun Nahar Ahmed, Mithun Kumar Sarkar, Raisah Jaheen, Muktasid Ud Daullah, Shahriar Khan, Mir Mubin, Habibur Rahman, Faiza Islam et al. · 2021 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  22. Characterizing cancer and COVID-19 outcomes using electronic health records
    Youngran Kim, Liang Zhu, Huili Zhu, Xiaojin Li, Yan Huang, Chunhui Gu, Heather Bush, Caroline D. Chung, Guo‐Qiang Zhang · 2022 · PLoS ONE
  23. Management of cancer patients during COVID-19 pandemic at developing countries
    Jaime González‐Montero, Guillermo Valenzuela, Mónica Ahumada, Olga Barajas, Luis Villanueva · 2020 · World Journal of Clinical Cases
  24. Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort
    Talvinder Bhogal, Umair Khan, Rebecca J. Lee, Alexander J. Stockdale, Christian Hesford, Vaishnav Potti-Dhananjaya, Avith Jathanna, Shaun Rahman, Ann Tivey, Rohan Shotton et al. · 2021 · Leukemia & lymphoma/Leukemia and lymphoma
  25. More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study
    Caterina Monari, Caterina Sagnelli, Paolo Maggi, Vincenzo Sangiovanni, Fabio Giuliano Numis, Ivan Gentile, Alfonso Masullo, Carolina Rescigno, Giosuele Calabria, Matteo Megna et al. · 2021 · Frontiers in Oncology
  26. Modeling the onset of symptoms of COVID-19: Effects of SARS-CoV-2 variant
    Joseph Larsen, Margaret R. Martin, John D. Martin, James B Hicks, Peter Kühn · 2021 · PLoS Computational Biology
  27. MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infection
    Lanlan Zhou, Kelsey E. Huntington, Shengliang Zhang, Lindsey Carlsen, Eui Young So, Cassandra Parker, İlyas Şahin, Howard P. Safran, Suchitra Kamle, Chang-Min Lee et al. · 2020 · Oncotarget
  28. Outcomes of COVID-19 Patients under Cytotoxic Cancer Chemotherapy in Brazil
    Mateus Bringel Oliveira Duarte, Frederico Rodrigues Póvoa Leal, Juliana Luz Passos Argenton, José Barreto Campello Carvalheira · 2020 · Cancers
  29. Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO Registry
    Kathryn Finch Mileham, Suanna S. Bruinooge, Charu Aggarwal, Alicia L. Patrick, Christiana W. Davis, Daniel J. Mesenhowski, Alexander I. Spira, Eric J. Clayton, David Michael Waterhouse, Susan G Moore et al. · 2021 · JCO Oncology Practice
  30. Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis
    Abraham Degarege, Zaeema Naveed, Josiane Kabayundo, David M. Brett‐Major · 2022 · Pathogens
  31. Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG
    Melissa Bersanelli, Diana Giannarelli, Ugo De Giorgi, Sandro Pignata, Massimo Di Maïo, Elena Verzoni, Alberto Clemente, Valentina Guadalupi, Diego Signorelli, Marcello Tiseo et al. · 2020 · Therapeutic Advances in Medical Oncology
  32. A Systematic Review and Meta-Analysis of Clinical Characteristics and Outcomes in Patients With Lung Cancer with Coronavirus Disease 2019
    Monica Peravali, Ishani Joshi, Jaeil Ahn, Chul Kim · 2021 · JTO Clinical and Research Reports
  33. Immunotherapy or other anti-cancer treatments and risk of exacerbation and mortality in cancer patients with COVID-19: a systematic review and meta-analysis
    Bolin Wang, Yan Huang · 2020 · OncoImmunology
  34. Clinical outcomes of patients hospitalized for COVID-19 and evidence-based on the pharmacological management reduce mortality in a region of the Colombian Caribbean
    Mara García-Posada, Sandra Aruachan-Vesga, Danis Mestra Rojas, Katherine Humánez, Hector Alejandro Serrano Coll, Heriberto José Cabrales Dajil, Álvaro Faccini, Salim Mattar V · 2021 · Journal of Infection and Public Health
  35. A prospective cohort study of the safety of breast cancer surgery during COVID-19 pandemic in the West of Scotland
    László Romics, Julie Doughty, Sheila Stallard, James Mansell, Vivienne Blackhall, Alison Lannigan, Suzanne Elgammal, Judith Reid, Marie-Claire McGuigan, Francesca Savioli et al. · 2020 · The Breast
  36. Prolonged viral replication in patients with hematologic malignancies hospitalized with COVID-19
    Carolina García‐Vidal, Pedro Puerta‐Alcalde, Aina Mateu, Genoveva Cuesta, Fernanda Salazar Meira, Carlos Lopera, Patricia Monzó, Marta Santos Bravo, Gerard Dueñas, Mariana Chumbita et al. · 2022 · Haematologica
  37. Comprehensive Oncogenic Features of Coronavirus Receptors in Glioblastoma Multiforme
    Anjing Chen, Wenguo Zhao, Xiaolong Li, Guangyu Sun, Zhaoyin Ma, Lingyu Peng, Zhongyang Shi, Xingang Li, Jie Yan · 2022 · Frontiers in Immunology
  38. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients
    Yu-Jun Dai, Wei-Na Zhang, Wei-Da Wang, Si-Yuan He, Cheng-Cai Liang, Da-Wei Wang · 2020 · International Journal of Biological Sciences
  39. A case series of children and young people admitted to a tertiary care hospital in Germany with COVID-19
    Jonathan Remppis, Tina Ganzenmueller, Malte Kohns Vasconcelos, O. Heinzel, Rupert Handgretinger, Hanna Renk · 2021 · BMC Infectious Diseases
  40. Economic Distress of Breast Cancer Patients Seeking Treatment at a Tertiary Cancer Center in Mumbai during COVID-19 Pandemic: A Cohort Study
    Tabassum Wadasadawala, Soumendu Sen, Rakesh Watekar, Pallavi Pratisad Rane, Rajiv Sarin, Sudeep Gupta, Vani V. Parmar, Sadhana Kannan, Sanjay Mohanty · 2021 · Asian Pacific Journal of Cancer Prevention
  41. Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer
    Hongshan Ye, Ning Zhang · 2021 · Computational and Mathematical Methods in Medicine
  42. Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options
    Waleed Kian, Melanie Zemel, Emily H. Kestenbaum, Keren Rouvinov, Wafeek Alguayn, Dina Levitas, Anna Ievko, Regina Michlin, Moataz A. Abod, Ismaell Massalha et al. · 2022 · Medicine
  43. Procalcitonin Has Good Accuracy for Prognosis of Critical Condition and Mortality in COVID-19: A Diagnostic Test Accuracy Systematic Review and Meta-analysis
    Mohammad Erfan Zare, Yanzhong Wang, Atefeh Nasir Kansestani, Afshin Almasi, Jun Zhang · 2020 · Iranian Journal of Allergy Asthma and Immunology
  44. The Landscape of COVID-19 in Cancer Patients: Prevalence, Impacts, and Recommendations
    Omar Abdihamid, Changjing Cai, Linda Kapesa, Shan Zeng · 2020 · Cancer Management and Research
  45. Participant flow diagrams for health equity in AI
    Jacob Ellen, João Carlos Ramos Gonçalves de Matos, Martin Viola, Jack Gallifant, Justin Michael Quion, Leo Anthony Celi, Nebal S. Abu Hussein · 2024 · Journal of Biomedical Informatics
  46. Clinical features and outcomes of COVID ‐19 in patients with solid tumors: Turkish National Registry Data
    Nuriye Özdemir, Ömer Dızdar, Ozan Yazıcı, Sercan Aksoy, Didem Şener Dede, Burçin Budakoğlu, Gökhan Metan, Alpaslan Alp, Işıl İrem Budakoğlu, Berna Çakmak Öksüzoğlu et al. · 2020 · International Journal of Cancer
  47. Bruton tyrosine kinase inhibitors as potential therapeutic agents for COVID-19: A review
    Zemene Demelash Kifle · 2021 · Metabolism Open
  48. Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients
    Pierre‐Etienne Heudel, Bertrand Favier, Marie-Laure Solodky, Souad Assaad, Natacha Chaumard, Olivier Trédan, Thomas Bachelot, Isabelle Laure Ray-Coquard, Bruno Russias, Marie-Line Fournier et al. · 2022 · European Journal of Cancer
  49. Influenza and pneumonia-attributed deaths among cancer patients in the United States; a population-based study
    Omar Mohammed Abdel-Rahman · 2020 · Expert Review of Respiratory Medicine
  50. The effects of COVID-19 pandemic on emergency anterior abdominal wall hernia surgery: is it safe to postpone elective hernia surgery in the pandemic?
    Ümit Turan, Ahmet Barış Dirim · 2021 · European Journal of Trauma and Emergency Surgery
  51. Lung Cancer Screening Considerations During Respiratory Infection Outbreaks, Epidemics or Pandemics: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report
    Rudolf Maria Huber, Milena R. Cavic, Anna Kerpel-Fronius, Lucía Viola, John K. Field, Long Jiang, Ella Annabelle Kazerooni, Coenraad F.N. Koegelenberg, Anant Mohan, Ricardo Sales dos Santos et al. · 2021 · Journal of Thoracic Oncology
  52. COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study
    Valerie Elizabeth Crolley, Daire Hanna, Nalinie Joharatnam‐Hogan, Neha Chopra, Ekin Bamac, Meera Desai, Yuk-Chun Lam, Sabiq Dipro, Ruhi Kanani, Jack Benson et al. · 2020 · Therapeutic Advances in Medical Oncology
  53. Clinical Course of Cancer Patients With COVID-19: A Retrospective Cohort Study
    Naomi Alpert, Joseph L. Rapp, Bridget Kelly Marcellino, Wil Lieberman‐Cribbin, Raja Michael Flores, Emanuela Taioli · 2020 · JNCI Cancer Spectrum
  54. Impact of COVID-19 pandemic on a daily-based outpatient treatment routine: experience of a radiotherapy department of a tertiary public/university hospital in Brazil
    Heloísa de Andrade Carvalho, Karina Gondim Moutinho da Conceição Vasconcelos, Herbeni Cardoso Gomes, João Víctor Salvajoli · 2020 · Clinics
  55. Sex Differences in the Incidence and Risk Factors of Myocardial Injury in COVID-19 Patients: A Retrospective Cohort Study
    Ran Cheng, Chuan Liu, Jie Wu Yang, Yuanqi Yang, Renzheng Chen, Xiaohan Ding, Xubin Gao, Jingbin Ke, Fangzhengyuan Yuan, Chunyan He et al. · 2021 · Frontiers in Physiology
  56. Comparison and impact of COVID-19 for patients with cancer: a survival analysis of fatality rate controlling for age, sex and cancer type
    Haiquan Li, Edwin Baldwin, Xiang Zhang, Colleen Kenost, Wenting Luo, Elizabeth A. Calhoun, Lingling An, Charles Lee Bennett, Yves A. Lussier · 2021 · BMJ Health & Care Informatics
  57. Delay in Diagnosis and Treatment of Primary Bone Tumors during COVID-19 Pandemic in Poland
    Daniel Kotrych, Dawid Ciechanowicz, Jakub Pawlik, Martyna Szyjkowska, Bartłomiej Kwapisz, Maciej Mądry · 2022 · Cancers
  58. Epidemiological and clinical characteristics of cancer patients with COVID-19: A systematic review and meta-analysis of global data
    Xiangyi Kong, Yihang Qi, Junjie Huang, Yang William Zhao, Yongle Zhan, Xuzhen Qin, Zhihong Qi, Adejare Jay Atanda, Lei Zhang, Yi Fang et al. · 2021 · Cancer Letters
  59. Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection
    MUHAMMAD BILAL LATIF, Sudhanshu Shukla, Perla M. Del Río Estrada, Susan Pereira Ribeiro, Rafick‐Pierre Sékaly, Ashish Sharma · 2021 · Translational research
  60. Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection
    Thilo Gambichler, Judith Reuther, Christina Scheel, Laura Susok, Peter Kern, Jürgen Christian Becker · 2020 · Cancers
  61. COVID-19 in cancer patients
    Suranjith Luke Seneviratne, Widuranga Wijerathne, Pamodh Chanuka Yasawardene, Buddhika Somawardana · 2022 · Transactions of the Royal Society of Tropical Medicine and Hygiene
  62. The impact of anti-tumor approaches on the outcomes of cancer patients with COVID-19: a meta-analysis based on 52 cohorts incorporating 9231 participants
    Qing Wu, Shuimei Luo, Xianhe Xie · 2022 · BMC Cancer
  63. Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2
    Jiewen Fu, Binghui Song, Jiaman Du, Shuguang Liu, Jiayue He, Ting Xiao, Baixu Zhou, Xiaoyan Liu, Xiaoyan Liu, Tao He et al. · 2022 · Molecular Biology Reports
  64. Pathophysiology of SARS-CoV-2 in Lung of Diabetic Patients
    Tales Lyra de Oliveira, Igor Santana de Melo, Léia Cardoso-Sousa, Igor Andrade Santos, Mohamad Bassim El Zoghbi, Caroline Gusson Shimoura, Renata Pereira Georjutti, Olagide Wagner de Castro, Luíz Ricardo Goulart, Ana Carolina Gomes Jardim et al. · 2020 · Frontiers in Physiology
  65. Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19
    Samuel M. Rubinstein, Divaya Bhutani, Ryan C. Lynch, Chih-Yuan Hsu, Yu Shyr, Shailesh Advani, Ruben A. Mesa, Sanjay Mishra, Daniel P. Mundt, Dimpy P. Shah et al. · 2022 · Blood Cancer Discovery
  66. The SARS-CoV-2 Outbreak: an Epidemiological and Clinical Perspective
    Rebecca Shin-Yee Wong · 2020 · SN Comprehensive Clinical Medicine
  67. Is it Safe to Perform Elective Colorectal Surgical Procedures during the COVID-19 Pandemic? A Single Institution Experience with 103 Patients
    Lucas Faraco Sobrado, Caio Sérgio Rizkallah Nahas, Carlos Frederico Sparapan Marques, Guilherme Cutait de Castro Cotti, Antônio Rocco Imperiale, Pedro Averbach, José Donizeti de Meira Júnior, Natally de Souza Maciel Rocha Horvat, Ulysses Ribeiro, Ivan Cecconello et al. · 2021 · Clinics
  68. Susceptibility of lung cancer patients to COVID ‐19: A review of the pandemic data from multiple nationalities
    Ana Lemos, Gabriela Ribeiro Silva, Etel Rodrigues Pereira Gimba, Aline da Rocha Matos · 2021 · Thoracic Cancer
  69. Prognostic Value of Pro-Inflammatory Neutrophils and C-Reactive Protein in Cancer Patient With Coronavirus Disease 2019: A Multi-Center, Retrospective Study
    Bo Zhang, Yuanhang Yu, Shawna Marie Hubert, Yue Zhang, Jianhua Lu, Shihua Liu, Fang Xie, Liang Zhao, Xiao Lei, Wei Deng et al. · 2020 · Frontiers in Pharmacology
  70. Covid-19 intensive care admissions and mortality among swedish patients with cancer
    Gunnar Larfors, Simon Pahnke, Maria State, Katarina Fredriksson, David R. Pettersson · 2020 · Acta Oncologica
  71. Higher severity and risk of in‐hospital mortality for COVID‐19 patients with cancer during the year 2020 in Brazil: A countrywide analysis of secondary data
    Guilherme Jorge Costa, Carla Rameri Alexandre Silva de Azevedo, José Iran Costa Júnior, Anke K. Bergmann, Luiz Cláudio Santos Thuler · 2021 · Cancer
  72. Hyperglycosylated spike of SARS-CoV-2 gamma variant induces breast cancer metastasis.
    Hsiang‐Chi Huang, Chun‐Che Liao, Shih‐Han Wang, I‐Jung Lee, Te-An Lee, Jung-Mao Hsu, Chun‐Tse Kuo, Jyun Wang, Wan-Chen Hsieh, Shing‐Jyh Chang et al. · 2021 · Europe PMC (PubMed Central)
  73. Clinical Characteristics, Care Trajectories and Mortality Rate of SARS-CoV-2 Infected Cancer Patients: A Multicenter Cohort Study
    Marc‐Antoine Benderra, Ainhoa Aparicio, Judith Leblanc, Demián Wassermann, Emmanuelle Kempf, Gilles Galula, Mélodie Bernaux, Anthony Canellas, Thomas Moreau, Ali Bellamine et al. · 2021 · Cancers
  74. Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality
    Maximilian F. Stahl, Varun K. Narendra, Justin Jee, Andriy Derkach, Molly Maloy, Mark Blaine Geyer, Anthony R. Mato, Lindsey Elizabeth Roeker, Martin S. Tallman, Gunjan L. Shah et al. · 2021 · Leukemia & lymphoma/Leukemia and lymphoma
  75. Ginsenoside Rg3, a promising agent for NSCLC patients in the pandemic: a large-scale data mining and systemic biological analysis
    Zhenjie Zhuang, Qianying Chen, Xiaoying Zhong, Huiqi Chen, Runjia Yu, Ying Tang · 2022 · Journal of Ginseng Research
  76. The impact of the Covid-19 pandemic on quality of life in skin cancer patients
    Jonas K. Kurzhals, Gina Klee, Hauke S. Busch, Victoria Hagelstein, Detlef Zillikens, Patrick Andres Maximilian Terheyden, Ewan Andrew Langan · 2021 · PLoS ONE
  77. Impact of COVID-19 in gynaecological oncology care: a systematic rapid review
    Manolis Nikolopoulos, Manish K. Maheshwari, Stergios K. Doumouchtsis · 2021 · Archives of Gynecology and Obstetrics
  78. COVID-19 Vaccination Status and Hesitancy among Breast Cancer Patients after Two Years of Pandemic: A Cross-Sectional Survey
    Weijing Liu, Yunhao Wu, Ruoning Yang, Ruixian Chen, Ya Huang, Xin Zhao, Min Xie, Qintong Li, Qiang Wang, Jie Chen · 2022 · Vaccines
  79. Impact of anti‐SARS‐CoV‐2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study
    Giovanni Manfredi Assanto, Alice Di Rocco, Francesco Malfona, Marcello Capriata, Ilaria Del Giudice, Luigi Petrucci, Paola Girardi, Gianna Maria D’Elia, Maurizio Martelli, Giuseppe Gentile et al. · 2022 · Hematological Oncology
  80. Risk factors for mortality among lung cancer patients with covid-19 infection: A systematic review and meta-analysis
    Mingyue Wu, Siru Liu, Changyu Wang, Yuxuan Wu, Jialin Liu · 2023 · PLoS ONE
  81. COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches
    Sareh Kakavandi, Bahareh Hajikhani, Paniz Azizi, Fatemeh Aziziyan, Mohsen Nabi‐Afjadi, Marzieh Ramezani Farani, Hamidreza Zalpoor, Maryam Azarian, Mahdiyar Iravani Saadi, Behrouz Gharesi‐Fard et al. · 2024 · Cell Communication and Signaling
  82. Oncologic immunomodulatory agents in patients with cancer and COVID-19
    Justin Jee, Aaron James Stonestrom, Sean M. Devlin, Teresa Nguyentran, Beatriz Wills, Varun K. Narendra, Michael Bonner Foote, Melissa Amy Lumish, Santosha Adipudi Vardhana, Stephen M. Pastores et al. · 2021 · Scientific Reports
  83. Mortality in mechanically ventilated patients with COVID-19: a systematic review
    Maria Tsikala-Vafea, Raina Zhang, Markos Kalligeros, Evangelia K. Mylona, Fadi Shehadeh, Eleftherios E Mylonakis · 2021 · Expert Review of Medical Devices
  84. SARS-CoV-2 genomic and quasispecies analyses in cancer patients reveal relaxed intrahost virus evolution
    Juliana Domett Siqueira, Livia Ramos Goes, Brunna M. Alves, Pedro S. de Carvalho, Claudia Cicala, James A. Arthos, João P. B. Viola, Andréia Cristina de Melo, Marcelo Alves Soares, on behalf of the INCA COVID-19 Task Force · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  85. Clinical characteristics, risk factors and outcomes of cancer patients with COVID ‐19: A population‐based study
    Jiandong Zhou, Ishan Lakhani, Oscar Hou In Chou, Keith Sai Kit Leung, Teddy Tai Loy Lee, Michelle Vangi Wong, Zhen Li, Abraham Ka Chung Wai, Carlin Chang, Ian Chi Kei Wong et al. · 2022 · Cancer Medicine
  86. Caring for cancer patients in the Covid pandemic: choosing between the devil and deep sea
    Mainak Chakraborty, Manoj Pandey · 2020 · World Journal of Surgical Oncology
  87. Measures of infection prevention and incidence of SARS-CoV-2 infections in cancer patients undergoing radiotherapy in Germany, Austria and Switzerland
    Christiane Matuschek, Johannes Fischer, Stephanie Elisabeth Combs, Rainer Fietkau, Stefanie Corradini, Kurt S. Zänker, Edwin Bölke, Freddy Joel Djiepmo-Njanang, Bálint Ferenc Tamaskovics, Joachim Ernst Fischer et al. · 2020 · Strahlentherapie und Onkologie
  88. Two years of SARS-CoV-2 infection (2019–2021): structural biology, vaccination, and current global situation
    Waqar Ahmad, Khadija Shabbiri · 2022 · The Egyptian Journal of Internal Medicine
  89. COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination
    Maxwell Salvatore, Miriam M. Hu, Lauren J. Beesley, Alison M. Mondul, Celeste Leigh Pearce, Christopher Ryan Friese, Lars G. Fritsche, Bhramar Mukherjee · 2023 · Cancer Epidemiology Biomarkers & Prevention
  90. Patient safety associated with the surgical treatment of bone and soft tissue tumours during the COVID-19 pandemic—results from an observational study at the Oxford Sarcoma Service
    Raja Bhaskara Rajasekaran, Sanjeev Kotecha, Duncan Whitwell, Thomas D. A. Cosker, P S Critchley, Charles Anton Fries, David Pigott, Christopher L. M. H. Gibbons, Andrew Jonathan Carr · 2020 · International Orthopaedics
  91. Clinical characteristics, risk factors, and cardiac manifestations of cancer patients with COVID-19
    Yan Huang, Zhenhong Hu, Dong Hu, Zhou Quan, Xiaoyang Zhou, Guohua Fan, Xiu Chen, Xiaoxiong Liu, Zhonghe Zhang, Ganxiao Chen et al. · 2021 · Journal of Applied Physiology
  92. Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells
    Lanlan Zhou, Kelsey E. Huntington, Shengliang Zhang, Lindsey Carlsen, Eui Young So, Cassandra Parker, İlyas Şahin, Howard P. Safran, Suchitra Kamle, Chang Min Lee et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  93. Sex-specific epidemiological and clinical characteristics of Covid-19 patients in the southeast region of Bangladesh
    Md. Aminul Islam, Abdullah Al Marzan, Md. Sydul Islam, Samina Sultana, Md. Iftakhar Parvej, Mohammad Salim Hossain, Mohammad Tohid Amin, Farzana Ehetasum Hossain, Md Abdul Barek, Md. Shafiul Hossen et al. · 2021 · medRxiv
  94. When and for Whom Does Intensive Care Unit Admission Change the Prognosis in Oncology?—A Scoping Review
    Ioana Roxana Codru, Liliana Vecerzan · 2025 · Cancers
  95. An Asian Perspective of the Management of COVID-19: the Asian National Cancer Centers Alliance Led Regional Comparison
    Luh Komang Mela Dewi, Laureline Gatellier, Kanaga Sabapathy, Conjeevaram S. Pramesh, Min Dai, Tran Thanh Huong, Murat Gültekin, Erdenekhuu Nansalmaa, Khin Khin Htwe, Muhammed Aasim Yusuf et al. · 2020 · Asian Pacific Journal of Cancer Care
  96. The impact of COVID‐19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single‐center experience
    Holly Lee, Jason Tay, Peter Raymond Duggan, Sylvia McCulloch, Paola E. Neri, Nizar Jacques Bahlis, Victor Hugo Jimenez-Zepeda · 2020 · European Journal Of Haematology
  97. SARS-CoV-2 Infection in Cancer Patients: A Population-Based Study
    Manuel Zorzi, Stefano Guzzinati, Francesco Avossa, Ugo Fedeli, Arianna Calcinotto, Massimo Rugge · 2021 · Frontiers in Oncology
  98. Cancer trends and risk factors in China over the past 30 years (1990-2019)
    Weiwei Wu, Ruochen Zhang, Yiming Jin, Yan Lü, Zhonglei Lu, Tao Li, Liefu Ye, Lin Le, Yongbao Wei · 2023 · Journal of Cancer
  99. Clinical characteristics, therapeutic management, and prognostic factors of adult COVID-19 inpatients with hematological malignancies
    Yaogong Wu, Wenlan Chen, Wenjing Li, Miaomiao Zhao, Qiuzhe Wei, Xiaoping Zhang, Heng Mei, Yadan Wang, Yu Hu · 2020 · Leukemia & lymphoma/Leukemia and lymphoma
  100. IMPACT OF COVID-19 IN PATIENTS WITH CANCER: A SCOPING REVIEW
    Tâmara Taynah Medeiros da Silva, Naryllenne Maciel de Araújo, Sabrina Daiane Gurgel Sarmento, Grayce Louyse Tinôco de Castro, Daniele Vieira Dantas, Rodrigo Assis Neves Dantas · 2021 · Texto & Contexto - Enfermagem